sunitha gurrala

Dr. sunitha gurrala


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2021 in Journal of Chromatographic Science
Verified
Journal Article
Closed access
SGsunitha gurrala
sunitha gurrala
SRShiva Raj
Shiva Raj
SCSubrahmanyam Cvs
Subrahmanyam Cvs
PAPanikumar Durga Anumolu
Panikumar Durga Anumolu
New analytical quality by design-oriented HPLC method with multiple response optimization (Derringer’s desirability function) was demonstrated for simultaneous analysis of three antidiabetic drugs (metformin hydrochloride/empagliflozin/linagliptin) in a fixed-dose combination. Central composite design was employed for systematic optimization of critical method parameters, namely, % organic phase (X1), aqueous phase pH (X2) and flow rate (X3) while resolution, capacity factor and theoretical plate number as critical analytical attributes. Effective chromatographic separation of title analytes was accomplished on Std. Discovery C18 column at 30°C with mobile phase comprising acetonitrile: phosphate buffer pH 5 (38:62% v/v), pumped at a flow rate of 1 mL/min by isocratic elution pattern and UV detection at 222 nm. The model is rectilinear in the range of 1.0–200, 0.2–40 and 0.1–20 μg/mL at retention times of 3.04, 3.93 and 5.99 min for metformin, empagliflozin and linagliptin, respectively. The method obeyed all validation parameters of ICH Q2(R1) guidelines. The proposed HPLC method was highly robust for method transfer, regulatory flexibility within design space and can be used for assay of pharmaceutical dosage forms comprising these analytes. The proposed method was applied for stability studies of drugs under various stress conditions.

11 November 2019 in Indian Journal of Pharmaceutical Education and Research
Verified
Journal Article
Open access
SGsunitha gurrala
sunitha gurrala
SSShivaraj Shivaraj S
Shivaraj Shivaraj S
SSSubrahmanyam Cvs Subrahmanyam
Subrahmanyam Cvs Subrahmanyam
PAPanikumar Durga Anumolu
Panikumar Durga Anumolu
GSGowthami Saraf
Gowthami Saraf
SHShivaraj
Shivaraj

1 January 2020 in The Thai Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SGsunitha gurrala
sunitha gurrala
PAPanikumar Durga Anumolu
Panikumar Durga Anumolu
SMSahitya Menkana
Sahitya Menkana
NGNikitha Gandla
Nikitha Gandla
KTKeerthi Toddi
Keerthi Toddi
Background: Two specific spectrophotometric methods (visible region) have been established using water as a solvent and validated for the analysis of linagliptin in API and pharmaceutical dosage forms. Materials and Methods: Method-A is established on th.

17 July 2018 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SNSwathi Naraparaju
Swathi Naraparaju
PAPani Kumar D. Anumolu
Pani Kumar D. Anumolu
SGsunitha gurrala
sunitha gurrala
RGRajeshwari Galennagari
Rajeshwari Galennagari
The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneous quantification of tamsulosin hydrochloride and solifenacin succinate. First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes. Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacin succinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride). Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL for solifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as per the ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochloride and 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim. The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.

25 February 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SGsunitha gurrala
sunitha gurrala
SRShiva Raj
Shiva Raj
SCSubrahmanyam Cvs
Subrahmanyam Cvs
DADurga Panikumar Anumolu
Durga Panikumar Anumolu
SNSwathi Naraparaju
Swathi Naraparaju
HNHarika Nizampet
Harika Nizampet
Design of experiments assisted spectrophotometric methods have been established for the quantification of saxagliptin in pharmaceutical formulation via charge transfer complexation and Schiff’s base formation. Box-Behnken design was exploited in method-1, involved the measurement of absorbance of green/blue-colored complex (at 600 nm), formed by the reaction of saxagliptin with 3-methyl-2-benzothiazolinone hydrazone in the presence of ferric chloride. The central composite design was employed in method-2, involved the determination of absorbance of Ruhemann’s purple (at 585 nm), formed by the reaction of the primary amine group of saxagliptin with ninhydrin reagent in presence of sodium hydroxide. Optimization of reaction variables namely, reagent concentration (A), oxidizing agent/alkalinity (B) and reaction/heat time (C) was performed through response surface methodology for the response (Y) i.e. absorbance of colored compound. The reliability of both methods was investigated through validation as per International Council for Harmonisation guidelines. Saxagliptin executed linearity in the concentration range of 0.01-0.25 μg/mL and 1-10 μg/mL by method-1 and 2. A high value of molar absorptivity, low values of Sandell’s sensitivity and limit of detection/limit of quantification divulges the good sensitivity methods. The % assay of saxagliptin in the marketed formulation was found to be 100.27 and 99.86 by method-1 and method-2, respectively. The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms.

1 March 2019 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PAPanukumar Durga Anumolu
Panukumar Durga Anumolu
SGsunitha gurrala
sunitha gurrala
SSSubrahmanyam Chavali Venkata Satya
Subrahmanyam Chavali Venkata Satya
SPSantoshi Vani Polisetty
Santoshi Vani Polisetty
ARAnjana Ravindran
Anjana Ravindran
RARadhagayathri Achanta
Radhagayathri Achanta
Nowadays, the market is flooded with combinations of drugs in various dosage forms, but there is a lack of official methods to quantify them. A single dissolution test method for the analysis of combined dosage form is preferred for simplification of quality control testing. If the developed dissolution medium mimics the biorelevant and discriminating dissolution procedure for drug products with limited drug aqueous solubility it is a useful tool for qualitative forecasting of the in vivo behavior of formulations. Dissolution profiles were evaluated for atorvastatin and fenofibrate in capsules, using a paddle-type United States Pharmacopeia dissolution apparatus in 900 mL of medium at 50 rpm and 37±0.5°C. The best medium was 900 mL of 0.5% w/v sodium lauryl sulfate. The cumulative % dissolution was more than 85% within 45 min for marketed tablets. The proposed dissolution test conditions have discriminative power, dissimilarity factor (f1) values are low (12-16%), and similarity (f2) factor values are also low (45-48%). Hence the use of 0.5% w/v sodium lauryl sulfate solution is justified. The dissolution method was validated (% relative standard deviation <2). To quantify both drugs simultaneously, a second derivative spectrophotometric method was established (λmax 281 nm and 296 nm, respectively, for atorvastatin and fenofibrate) in acetate buffer, pH 2.8 solution.